Navigation Links
deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business
Date:10/15/2008

REYKJAVIK, Iceland, Oct. 15 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced that the company is carrying out a review of its long-term business strategy. Over the past few years deCODE has utilized its capabilities in medicinal chemistry, structural biology and human genetics to develop product and intellectual property portfolios in both therapeutics and DNA-based diagnostics. The goal of this strategic review is to optimize the value of these assets for its shareholders by sharpening the focus of its business, selling non-core assets, securing strategic partnerships, and utilizing the resources generated to underpin product development and marketing efforts in its core business. The company has engaged the Stanford Group Company to assist in evaluating deCODE's strategic alternatives and in executing swiftly on the results of this review through the identification of buyers and partners for non-core business units, programs and intellectual property. deCODE plans to provide an update on this process in its third quarter financial results conference call to be webcast live on November 6.

deCODE also announced that in order to provide more time for the completion of this review and the execution of alternatives including the sale of assets, it has elected to utilize a 30-day grace period for the scheduled October 15 interest payment on its outstanding 3.5% Senior Convertible Notes due 2011.

"We are in the process of creating a smaller, leaner deCODE that will devote its efforts and resources to one line of business. We have created a unique and growing portfolio of intellectual property, as well as a range of products and programs in both our drug development and diagnostics work, and are engaged in
'/>"/>

SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer
2. Open Biosystems Launches Decode RNAi Viral Screening Pools for Low-Cost Genome-Scale RNAi Screens
3. deCODE genetics to Webcast Presentation at Piper Jaffray Annual Healthcare Conference
4. deCODE genetics to Webcast Presentation at Lazard Capital Markets Annual Healthcare Conference
5. Wound Management Technologies, Inc. Announces Strategic Plans for Revenue Growth for Year End and 2009
6. Herley Industries, Inc. Engages Jefferies Quarterdeck to Explore Strategic Alternatives
7. ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association
8. Marex Group Forms Business Development Department and Promotes Three Strategic Employees
9. Covance and Lilly Enter Into a Strategic R&D Collaboration
10. U.S. Preventive Medicine(R) Forms Strategic Alliance with Physicians Planning Group
11. InfoLogix Launches Strategic Mobility Assessment Service for Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... After many ... , finally its here, http://www.express-glasses.com is proud to announce its collaboration ... ask about shipping with DHL Express when calling or visiting the express glasses ...
(Date:6/30/2015)... ... June 30, 2015 , ... Rocky Mountain Oils, a leading non-MLM supplier ... and added a new CEO, Mr. Darold Francis. The changes will help enhance the ... oils that customers have come to know and respect for over eight years. , ...
(Date:6/30/2015)... ... June 30, 2015 , ... MJH Associates ... HRA Healthcare Research & Analytics , a consultative healthcare market research practice ... family of businesses. HRA offers quantitative and qualitative, custom and multi-client primary market ...
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... ... News Digest discussed the advantages that fat transfer procedures had over breast ... using fat transfer techniques create breasts that “look and feel natural,” have increased ...
(Date:6/30/2015)... ... 2015 , ... Board certified otolaryngologist Dr. Marcelo B. Antunes ... , Dr. Antunes is a fellowship trained facial plastic surgeon with ... to performing cosmetic and reconstructive surgery on the face, he enjoys treating patients ...
Breaking Medicine News(10 mins):Health News:Eyeglasses Online - Express Glasses Announcing New International Shipping Using DHL 2Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3Health News:Recent Article Advocating for Breast Reconstruction with Fat Transfers Successfully Outlines the Advantages of Transfer Procedures, Notes Beverly Hills Physicians 2Health News:Recent Article Advocating for Breast Reconstruction with Fat Transfers Successfully Outlines the Advantages of Transfer Procedures, Notes Beverly Hills Physicians 3Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 3
... , Salad Bar to Be Donated to ... , , WASHINGTON, Aug. 19 The ... bar at its Fresh Festival event, September 9, in the Cannon House ... salad bar, stocked with fresh fruits and vegetables, will underscore the need ...
... , , NEW YORK, Aug. ... point-of-care digital signage network into major U.S. markets, including Detroit, Miami, ... demand for HMN,s services by healthcare providers and advertisers. Installations in ... markets is slated for the second half of 2009. HMN,s largest ...
... experts say , WEDNESDAY, Aug. 19 (HealthDay ... with the drug letrozole (Femara) increases survival after surgery ... confirms. , Both letrozole and tamoxifen have been used ... with hormone receptor-positive cancer, but whether one drug is ...
... , , , ... and BRISBANE, Calif., Aug. 19 Roche (SIX: ROG.VX; RO.S, OTCQX: ... that the first patient has been dosed in a Phase 2b ... in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). ...
... (August 19, 2009) Using a novel robot-assisted endoscopic ... of Medicine in Seoul, Korea, has successfully treated 200 ... which has several technical and cosmetic benefits that the ... the August issue of the Journal of the ...
... paraffin, suggest beeswax instead , WEDNESDAY, Aug. 19 (HealthDay ... ambiance, fragrance and light, may also contribute to air ... made from petroleum, are a source of known human ... to be presented Wednesday at the American Chemical Society,s ...
Cached Medicine News:Health News:United Fresh to Feature Salad Bar at Capitol Hill Event to Advocate National School Salad Bar Policy 2Health News:United Fresh to Feature Salad Bar at Capitol Hill Event to Advocate National School Salad Bar Policy 3Health News:Health Media Network Expands to New Markets 2Health News:Newer Drug Beats Tamoxifen for Older Breast Cancer Patients 2Health News:Newer Drug Beats Tamoxifen for Older Breast Cancer Patients 3Health News:Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C 2Health News:Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C 3Health News:Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C 4Health News:Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C 5Health News:Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C 6Health News:Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C 7Health News:Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C 8Health News:Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C 9Health News:Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C 10Health News:New robot-assisted surgical method found successful for treatment of thyroid cancer 2
(Date:6/30/2015)... , June 30, 2015 Nortek Security ... NTK ) and a leader in the ... today announced it acquired mobile personal emergency response ... held Numera, Inc. Headquartered in ... easily implemented, mobile PERS products and cloud-based software ...
(Date:6/30/2015)... -- IGI Laboratories, Inc. (NYSE MKT: IG), a ... today announced it has submitted its fifth abbreviated new ... Administration (FDA) of 2015, which brings the Company,s total ... to twenty-seven. Jason Grenfell-Gardner , President ... current pipeline of twenty-seven submissions, exclusive of our four ...
(Date:6/30/2015)... new way for people to keep their family safe, while ... is being introduced to the world via an Indiegogo ... $70,000, which needs to be raised in order to bring ... device was inspired by the many scenarios people face in ... day. While medical alert bracelets have been around for years, ...
Breaking Medicine Technology:Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 4IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015 2Amyko Propels Medical Alert Bracelets Into the Modern Era 2
... , DENVER , Feb. 11 ... and marketer of diagnostic test kits, today filed its 2nd quarter ... the company,s revenues slightly declined during the quarter but slightly increased ... of the results highlighted by the report are as follows: , ...
... MOUNTAIN VIEW, Calif. , Feb. 11 Alexza Pharmaceuticals, ... & Drug Administration has accepted the AZ-004 NDA for filing and ... of October 11, 2010 .  Alexza filed the AZ-004 NDA ... for the rapid treatment of agitation in patients with schizophrenia or ...
Cached Medicine Technology:Corgenix Reports Second Quarter Fiscal 2010 Financial Results 2Corgenix Reports Second Quarter Fiscal 2010 Financial Results 3Corgenix Reports Second Quarter Fiscal 2010 Financial Results 4Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010 2Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010 3
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
... Amvex offers a complete line ... heliox and CO 2 . They ... of calibrations to best suit your ... dials specific to the gas in ...
... Amvex offers a complete line ... heliox and CO 2 . They ... of calibrations to best suit your ... dials specific to the gas in ...
... Amvex offers a complete line of flowmeters, available ... are all available in a variety of calibrations to ... dials specific to the gas in use, the Amvex ... colors replace the U with I. For Power Take-Off ...
Medicine Products: